Lento Bio is developing small molecule eyedrops to treat presbyopia by increasing lens flexibility, with the goal of eliminating the need for corrective lenses
Learn about our research and approach to targeting age-related disease
<span data-metadata=""><span data-buffer="">Explore how Lento is leveraging strategic partnerships to drive R&D
<span data-metadata=""><span data-buffer="">Read about our leadership and development teams. Find resources on careers at Lento.
